Markets

Orchid Pharma Announces Investor Roadshow Featuring Whole Time Director Orchid Pharma Limited confirmed an Investor Roadshow scheduled for April 10, 2026. The event will feature Mr. Mridul Dhanuka, the Whole Time Director of the company.The details for the investor meeting are as follows:Day & DateMeeting TypeModePlaceFriday, April 10, 2026Group MeetPhysicalGurugramThe company stated that no Unpublished Price Sensitive Information is proposed to be shared by Orchid Pharma Limited during the investor meet.ORCHPHARMA Stock Price Movement Orchid Pharma Limited shares shed 2.46% today, closing at ₹518.4 after sliding by ₹13.05 in after-hours trading. The stock saw a total volume of 96,616 shares traded for the day.Source:

Independent Director Resignation: Sanjeev Kishore Steps Down from Century Extrusions Limited Board Sanjeev Kishore has tendered his resignation as an Independent Director of Century Extrusions Limited, effective from the closure of business hours on April 7, 2026.The resignation announcement indicates that Mr. Kishore has decided to step down to explore new professional opportunities within the corporate advisory space, with a specific focus on supporting and advising Micro, Small and Medium Enterprises (MSMEs).The resignation letter confirms that there are no other material reasons for his departure beyond those stated.Details regarding the change in directorship are as follows:ParticularsDetailsNameMr. Sanjeev Kishore...

RDB Infrastructure And Power Ltd Receives Award for Solar Cell Manufacturing Plot in Chhattisgarh RDB Infrastructure And Power Ltd, in consortium with M/s Samvik Power Private Limited, has received a Notice of Award for an industrial plot designated for the development of a Solar Cell Manufacturing/Processing and allied Industry. The award was received from Nava Raipur Atal Nagar Vikas Pradhikaran via email on April 7, 2026, and is for the location at Layer-II, Nava Raipur Atal Nagar, Raipur, Chhattisgarh.The allotment pertains to Industrial Plot LII/IND/PCD/1.A detailed breakdown of the award terms and conditions is provided below:DetailSpecificationName of Awarding EntityNava Raipur Atal Nagar Vikas PradhikaranNature of...

Archies Ltd Announces Resignation of Independent Director Archies Ltd announced that Mr. Rajinder Kumar Verma has tendered his resignation from the position of Non-Executive Independent Director. The resignation is effective from the close of business hours on March 11, 2026.The announcement confirms that Mr. Verma stated his resignation was due to personal reasons, as detailed in his resignation letter dated March 11, 2026. Mr. Verma also confirmed that there are no other material reasons for his departure aside from those stated in his resignation.Details of Resignation The key particulars surrounding the resignation of Mr. Rajinder Kumar Verma as an Independent Director are summarized below:ParticularsDetailsName of...

Tourism Finance Corporation of India Details Corporate Bond and Debenture Listings Tourism Finance Corporation of India Ltd provided an update detailing the listing status of its corporate bonds and non-convertible debentures (NCDs) on April 7, 2026. The information covers centralized data fields related to the company's borrowings.The company confirmed that there were no defaults or delays in servicing of Bonds/NCDs during the Financial Year 2025-26. Details concerning the payment status of interest and/or redemption of these instruments for FY 2025-26 were previously communicated to the stock exchanges under Regulation 57 of SEBI (LODR) Regulations, 2015.Listing Details of Bonds and NCDs The specifics of the Bonds/NCDs issued by...

Aurobindo Pharma Receives USFDA Approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets Aurobindo Pharma Limited announced the receipt of final approval from the US Food & Drug Administration (USFDA) for the manufacture and marketing of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets. The approved strengths are 5 mg/ 500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg.These products are reported to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xigduo XR Tablets, with strengths 5 mg/ 500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg, manufactured by AstraZeneca AB.The company stated that the approved drugs will be manufactured at Unit-IV of APL...

Wipro Ltd Allots Equity Shares Under ESOP Plans Wipro Ltd allotted shares under employee stock option plans on April 7, 2026. The company issued 66,880 equity shares under the ADS Restricted Stock Unit Plan 2004 and 35,646 equity shares under the Restricted Stock Unit Plan 2007.The allotment of these equity shares was executed on April 7, 2026, following the exercise of Employee Stock Option Plans (ESOPs).The details of the allotted shares are as follows:Plan NameNumber of Equity Shares AllottedADS Restricted Stock Unit Plan 200466,880Restricted Stock Unit Plan 200735,646WIPRO Stock Price Movement Today, Wipro Limited shares edged higher to close at ₹204.72, marking a gain of 3.71% in after-hours trading. The equity...

Eraaya Lifespaces Ltd Files Share Capital Audit Report Reconciliation for Quarter Ended March 31, 2026 Eraaya Lifespaces Ltd has released the Reconciliation of Share Capital Audit Report for the quarter ending March 31, 2026. The report details the company's share capital structure and changes during the period.The reconciliation report provides key figures regarding the company's share capital as of the specified quarter. The details are presented in the following table:MetricDetailValuePeriod End DateQuarter Ended31-03-2026ISIN INE432F01032Face Value Re. 1/-Company Name ERAAYA LIFESPACES LIMITEDRegistered Office 54, Janpath, New Delhi - 110001Issued Capital 20,66,94,160Listed Capital (BSE) 20,66,94,160...

Aurobindo Pharma Receives USFDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dapagliflozin Tablets, 5 mg and 10 mg. The approved drug is stated to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Farxiga Tablets, 5 mg and 10 mg, manufactured by AstraZeneca AB.These products will be manufactured at Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of the Company, and are scheduled for immediate launch.The market potential for the approved product is significant, with an estimated market size of US$ 10.2 billion for the twelve months...

GE Vernova T&D India Faces Customs Demand Following Import Assessment GE Vernova T&D India Ltd has confirmed a financial impact resulting from an assessment by the Joint Commissioner of Customs regarding imported goods. The company's obligations stem from an order received on April 6, 2026.The action taken by the customs authority involved the assessment of certain imported goods, which were initially assessed at concessional rates of Basic Customs Duty. The Joint Commissioner of Customs subsequently identified that the imported goods were not covered under these concessional rates, leading to a confirmed demand for a short-levied differential duty.The order issued by the authority on April 4, 2026, detailed the required financial...

Shivagrico Implements Ltd Addresses Share Price Movement with Market Conditions Explanation Shivagrico Implements Ltd stated that the movement in the company's share price is primarily due to market conditions. The company confirmed that it is in compliance with SEBI (LODR) Regulations, 2015, and has promptly informed the Stock Exchange regarding all events and information that may affect the company's operations or performance.The company asserted that it has not withheld any information or events that would impact the price behavior of the company's scrip, as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The company stated that the price movement is generally market...

Prostarm Info Systems Announces Strategic Realignment of Business Units Prostarm Info Systems Limited announced a strategic realignment of its business operations following a Board of Directors meeting held on April 07, 2026. The stated aim of the realignment is to enhance operational efficiency, optimize resource utilization, and strengthen the company's focus on core business areas.As part of this internal reorganization, the major UPS related business operations currently managed by the Company Unit, including those of its Wholly Owned Company, Prostarm Energy Systems Private Limited, will be gradually shifted to the Company's unit located in Bakrol, Gujarat.The company provided details regarding the unit operations for the...

Prostarm Info Systems to Collaborate on BESS Manufacturing with Shenzhen Topband Co. Ltd. Prostarm Info Systems Limited announced on April 7, 2026, that its Board of Directors approved signing a Memorandum of Understanding (MOU) with Shenzhen Topband Co. Ltd. This collaboration aims to establish a strategic alliance for the exclusive cooperation in the Battery Energy Storage System (BESS) manufacturing sector.The proposed MOU outlines a collaborative framework between Prostarm Info Systems Limited and Shenzhen Topband Co. Ltd., a limited liability company incorporated under the laws of the People's Republic of China.Under this framework, the roles of the partnering entities are clearly defined. Shenzhen Topband Co. Ltd. will be...

Amic Forging Ltd CFO Resigns Due to Personal Reasons Amic Forging Ltd has announced the resignation of Mr. Priyankar Ghosh, the company's Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective from April 1, 2026. The departure is attributed to personal reasons.The company confirmed that it is currently in the process of appointing a suitable candidate to fill the CFO and KMP position.Mr. Ghosh submitted his resignation letter stating his resignation from the post of Chief Financial Officer of Amic Forging Ltd with effect from 01.04.2026 on personal reasons. He confirmed that there are no other reasons apart from those mentioned in his resignation letter.For official records, the following key details regarding...

Prostarm Info Systems Ltd Signs MOU with Shenzhen Topband for BESS Manufacturing Collaboration Prostarm Info Systems Ltd has entered into a Memorandum of Understanding (MOU) with Shenzhen Topband Co. Ltd, a limited liability company incorporated under the laws of the People's Republic of China. The agreement aims to establish a strategic and collaborative framework for exploring an Exclusive Cooperation under Battery Energy Storage System (BESS) manufacturing.The MOU outlines a partnership where TOPBAND will provide Semi-Knocked Down (SKD) BESS kits, along with necessary technology and technical know-how. Prostarm Info Systems Ltd will manage the local assembly, integration, and subsequent commercialization of these systems within...

Prostarm Info Systems Secures Sub-Contract for 50 MWac Solar PV Power Project in Maharashtra Prostarm Info Systems Limited has received a Letter of Award (LOA) positioning the company as a sub-contractor for the complete Engineering, Procurement and Construction (EPC) works for a 50 MWac Solar PV Power Project in Maharashtra. This project is associated with Maharashtra State Power Generation Company Limited (MAHAGENCO).The total order value secured is approximately ₹165 Crores (Rupees One Hundred Sixty-Five Crores only), excluding GST. The LOA was accepted on April 07, 2026.The contract entails the execution of complete EPC works on a turnkey basis. Crucially, the scope of work excludes three years of Operation & Maintenance (O&M)...

MBL Infrastructure Ltd Announces Board Meeting on April 11, 2026 MBL Infrastructure Ltd announced a meeting of its Board of Directors scheduled for Saturday, April 11, 2026. The board is set to consider several key resolutions concerning the company's future structure and capital raising.The agenda for the board meeting includes considering a proposal for obtaining shareholder approval regarding the raising of funds. This financing could involve the issuance of securities, denominated either in Indian Rupee or foreign currency, through various methods. These methods include public issue, private placement (including qualified institutions placement), or any other mode permitted under the Companies Act, 2013 and/or SEBI Regulations...

Prostarm Info Systems Secures ₹165 Crores Sub-Contract for 50 MWac Solar PV Project in Maharashtra Prostarm Info Systems Limited announced on April 07, 2026, that it has secured a Letter of Award (LOA) to function as a sub-contractor for a significant renewable energy project. The contract involves the execution of complete Engineering, Procurement and Construction (EPC) works for a 50 MWac Solar PV Power Project located in the State of Maharashtra.The project was awarded under a larger initiative managed by the Maharashtra State Power Generation Company Limited (MAHAGENCO). Solarium Green Energy Limited awarded the contract to Prostarm Info Systems Ltd. The total order value for the EPC works is approximately ₹165 Crores (Rupees One...

Innovision Ltd Independent Director Sudha Hooda Resigns Innovision Ltd confirmed the resignation of its Independent Director, Ms. Sudha Hooda, effective April 6, 2026. The resignation was tendered due to other professional commitments and personal reasons.Ms. Sudha Hooda's departure means she will also cease to serve as the Chairman and Member of the Audit Committee, and as a Member of the Nomination & Remuneration Committee of the Company.The Board of Directors of Innovision Ltd noted its appreciation for Ms. Sudha Hooda's valuable contribution and guidance during her tenure as an Independent Director.The details surrounding the change in directorship are summarized below:Sr.No.ParticularsDescription1Name and DINSudha...

Embassy Office Parks REIT Approves Issuance of Commercial Papers The Board of Directors of the Manager of Embassy Office Parks REIT has approved the issuance of listed, rated, redeemable, transferable, rupee denominated Commercial Papers (CPs).The Debenture Committee of the Board of Directors of the Manager held a meeting on April 07, 2026. During this meeting, the committee approved the issuance of Commercial Papers for an aggregate amount of ₹1,100 Crores.The issuance is structured in two tranches under the CP Tranche X Issue:CP Tranche X Issue A: ₹650 Crores, with a tenure of 347 days from the deemed date of allotment. CP Tranche X Issue B: ₹450 Crores, with a tenure of 342 days from the deemed date of allotment.This approval...